Related Experiment Videos
Bcl-2 prevents Bax oligomerization in the mitochondrial outer membrane
V Mikhailov1, M Mikhailova, D J Pulkrabek
1Department of Pathology, University of Texas Health Science Center, San Antonio, Texas 78229, USA.
The Journal of Biological Chemistry
|March 30, 2001
Summary
Bcl-2 protein prevents kidney cell death by inhibiting Bax protein oligomerization, a key step in apoptosis, without directly binding to Bax. This mechanism protects cells during ATP depletion.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Adenosine triphosphate (ATP) depletion triggers Bax translocation to mitochondria and cytochrome c release, initiating apoptosis in kidney cells.
- Bcl-2 overexpression inhibits cytochrome c release but does not affect ATP depletion or Bax translocation, suggesting a downstream protective mechanism.
Purpose of the Study:
- To investigate the in vivo molecular mechanisms of Bax translocation and Bcl-2's protective effects.
- To determine if Bax forms oligomers and if Bcl-2 interacts with Bax or other mitochondrial proteins.
Main Methods:
- Utilized bifunctional cross-linkers to stabilize protein adducts in ATP-depleted wild-type and Bcl-2-overexpressing kidney cells.
- Employed immunoprecipitation to assess protein-protein interactions, including Bax-Bcl-2, Bax-VDAC, and Bax-ANT.
- Investigated protein complex formation using nonionic detergents.
Main Results:
- Translocated Bax forms homo-oligomers in ATP-depleted cells, stabilized by cross-linkers.
- Bax remains monomeric in Bcl-2-overexpressing cells, indicating Bcl-2 prevents oligomerization.
- Bcl-2's protective effect does not rely on stable associations with Bax or other tested mitochondrial proteins (VDAC, ANT).
Conclusions:
- Bax's pro-apoptotic function in vivo is, at least partly, dependent on homo-oligomer formation.
- Bcl-2-mediated cytoprotection involves preventing Bax oligomerization, independent of direct Bax binding.